Transarterial chemoembolization (TACE) is a standard treatment for intermediate-stage
hepatocellular carcinoma (HCC). In this review, we summarize recent updates on the use of …

Importance Hepatocellular carcinoma (HCC) has the second-highest cancer-related
mortality rate in the world because most patients are diagnosed at an intermediate to …

Technologic advances have provided the means to deliver tumoricidal doses of radiation
therapy (RT) to patients with unresectable hepatocellular carcinoma (HCC) while avoiding …

The purpose of this paper is to evaluate the efficacy and safety of transcatheter arterial
chemoembolization (TACE) plus radiotherapy (RT) for unresectable hepatocellular …

BACKGROUND. Patients with advanced hepatocellular carcinoma (HCC) with portal vein
thrombosis (PVT) have a particularly grave prognosis. In the current study, an attempt was …

Background The objectives of this retrospective study was to evaluate the efficacy of
stereotactic body radiation therapy (SBRT) for small non-resectable hepatocellular …

Purpose: In order to determine the effect of additional radiotherapy (RT) after an incomplete
transcatheter arterial chemoembolization (TACE) in an unresectable hepatocellular …

The purpose of this study was to evaluate the clinical efficacy, toxicity and adverse effects of
stereotactic body radiotherapy (SBRT) combined with transarterial chemoembolization …

Purpose: To investigate the clinical benefit of additional radiotherapy to patients with
unresectable hepatocellular carcinoma treated with transcatheter arterial …

PURPOSE This study evaluated the effect of transcatheter arterial Chemoembolization
combined with external beam radiotherapy on the response rates and survival of patients …